tradingkey.logo
tradingkey.logo
Suchen

Apyx Medical Corp

APYX
Zur Watchlist hinzufügen
4.300USD
-0.360-7.73%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
180.03MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Apyx Medical Corp Unternehmen

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corp Informationen

BörsenkürzelAPYX
Name des UnternehmensApyx Medical Corp
IPO-datumJul 22, 1983
CEOGoodwin (Charles D)
Anzahl der mitarbeiter220
WertpapierartOrdinary Share
GeschäftsjahresendeJul 22
Addresse5115 Ulmerton Rd
StadtCLEARWATER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33760-4004
Telefon18005372790
Websitehttps://apyxmedical.com/
BörsenkürzelAPYX
IPO-datumJul 22, 1983
CEOGoodwin (Charles D)

Führungskräfte von Apyx Medical Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.90M
+7.91%
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
16.47K
+27.13%
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.90M
+7.91%
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
16.47K
+27.13%
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Apyx Medical Corp?

Die fünf größten Anteilseigner von Apyx Medical Corp sind: Mr. Stavros G. Vizirgianakis

Wie viele Institutionen halten Anteile an Apyx Medical Corp (APYX)?

Mit Stand vom 2026Q1 halten 105 Institutionen Anteile an Apyx Medical Corp, mit einem Gesamtmarktwert von etwa 19.57M, was 46.73% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1346948.00 gestiegen.